Visualizing Aβ Deposits in Live Young AD Model Mice with a Simple Red/near-Infrared-fluorescent AIEgen

Wang Yipu,Mei Dong,Zhang Xinyi,Qu Da-Hui,Mei Ju
DOI: https://doi.org/10.1007/s11426-021-1113-0
2021-01-01
Science China Chemistry
Abstract:Precise and early detection of β-amyloid(Aβ) deposits in situ and in real time is pivotal to the diagnosis and early intervention of Alzheimer’s disease(AD). Optical imaging stands out to be a promising technique for such a task; however, it still remains a big challenge, due to the lack of high-performance imaging contrast agent. Restricted by poor blood-brain barrier(BBB) penetrability, short-wavelength excitation and emission, as well as the aggregation-caused quenching effect, the widely used goldstandard probes cannot be used for early in-vivo imaging of Aβ deposits. Herein, we integrate the Aβ deposits-favored geometry,amphiphilic and zwitterionic molecular structure, extended D-π-A electronic structure, and 3 D conformation into one molecule,facilely establishing a simple and economic imaging contrast agent that enjoys high specificity and affinity to Aβ deposits, good BBB penetrability, bright red/near-infrared fluorescence, low interference from autofluorescence, aggregation-induced emission(AIE) feature, high signal-to-noise ratio(SNR), and high contrast. In-vitro, ex-vivo, and in-vivo experiments with different strains of mice indicate that AIE-CNPy-AD holds the universality to Aβ deposits identification. Noteworthily, AIE-CNPy-AD is even able to precisely trace the small and sparsely-distributed Aβ deposits in AD model mice as young as 4-month-old APP/PS1 mice,the youngest having Aβ deposits. Moreover, the present probe could clearly reveal the increase and enlargement of Aβ deposits as the mice grow. Therefore, AIE-CNPy-AD might be an ideal alternative for early AD diagnosis and highly reliable monitoring of AD progression.
What problem does this paper attempt to address?